Kintara Therapeutics, Inc. KTRA NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

37/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Kintara Therapeutics, Inc. (KTRA) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 35/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score

37/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

✓

未來

75/100

Analyst consensus

→ Forecast

✗

过去

0/100

→ Income

健康

67/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

28/100

→ Income

✗

成长

15/100

→ Income

—

收入

N/A

No coverage

估值概览 — KTRA

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.00

EV/EBITDA0.0

每股数据

EPS (TTM)$-1.21

每股账面价值$0.00

每股营收$0.00

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2016	$-404.86	$0.00	$-8.86M	-
2017	$-335.43	$0.00	$-8.08M	-
2018	$-266.96	$0.00	$-11.14M	-
2019	$-143.87	$0.00	$-7.41M	-
2020	$-48.39	$0.00	$-10.11M	-
2021	$-74.02	$0.00	$-38.32M	-
2022	$-25.80	$0.00	$-22.66M	-
2023	$-9.27	$0.00	$-14.65M	-
2024	$-3.23	$0.00	$-8.5M	-
2025	$-1.21	$0.00	$-22.65B	-